UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.937

Sortiert nach

Long‐term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real‐world data (KCSG LU20‐11)

Cancer, 2022-02, Vol.128 (4), p.778-787

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)

BMC cancer, 2024-02, Vol.24 (1), p.252-252, Article 252

2024

Link zum Volltext

Verfügbarkeit prüfen

Quality of end‐of‐life care in patients with hematologic malignancies: A retrospective cohort study

Cancer, 2014-05, Vol.120 (10), p.1572-1578

2014

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and Outcomes of Patients Admitted to the Acute Palliative Care Unit From the Emergency Center

Journal of pain and symptom management, 2014-06, Vol.47 (6), p.1028-1034

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR - or ALK -Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

Journal of clinical oncology, 2024-04, Vol.42 (11), p.1241

2024

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Outcomes of the Busan Community-based Palliative Care Project in Korea

Asian Nursing Research, 2018, 12(4), , pp.286-292

2018

Link zum Volltext

Verfügbarkeit prüfen

Avoidable and Unavoidable Visits to the Emergency Department Among Patients With Advanced Cancer Receiving Outpatient Palliative Care

Journal of pain and symptom management, 2015-03, Vol.49 (3), p.497-504

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01)

BMC cancer, 2020-08, Vol.20 (1), p.813-9, Article 813

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study

Oral oncology, 2024-04, Vol.151, p.106739-106739, Article 106739

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas

Cancer, 2012-12, Vol.118 (24), p.6162-6170

2012

Link zum Volltext

Verfügbarkeit prüfen

Multi-center, randomized, double-blind, placebo-controlled, exploratory study to evaluate the efficacy and safety of HAD-B1 for dose-finding in EGFR positive and locally advanced or metastatic NSCLC subjects who need Afatinib therapy: Study protocol clinical trial (SPIRIT Compliant)

Medicine (Baltimore), 2020-01, Vol.99 (4), p.e18735-e18735

2020

Link zum Volltext

Verfügbarkeit prüfen

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer

Journal of Clinical Neurology, 2018, 14(1), , pp.115-117

2018

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive approaches to managing delirium in patients with advanced cancer

Cancer treatment reviews, 2013-02, Vol.39 (1), p.105-112

2013

Link zum Volltext

Verfügbarkeit prüfen

Totality outcome of afatinib sequential treatment in patients with EGFR mutation-positive non-small cell lung cancer in South Korea (TOAST): Korean Cancer Study Group (KCSG) LU-19-22

Translational lung cancer research, 2022-07, Vol.11 (7), p.1369-1379

2022

Link zum Volltext

Verfügbarkeit prüfen

Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors

Cancers, 2022-07, Vol.14 (14), p.3440

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01)

Cancers, 2023-01, Vol.15 (2), p.471

2023

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01)

The Korean Journal of Internal Medicine, 2022, 37(1), , pp.190-200

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study

Clinical and applied thrombosis/hemostasis, 2021, Vol.27, p.1076029620979575

2021

Link zum Volltext

Verfügbarkeit prüfen

Opioid Withdrawal Syndrome After Treatment With Low-Dose Extended-Release Oxycodone and Naloxone in a Gastric Cancer Patient With Portal Vein Thrombosis

Journal of pain and symptom management, 2013-08, Vol.46 (2), p.e15-e17

2013

Link zum Volltext

Verfügbarkeit prüfen

Avoidable and Unavoidable Visits to the Emergency Department Among Advanced Cancer Patients (AdCa) Followed by the Supportive Care (SCPC) Outpatient Clinic (S715)

Journal of pain and symptom management, 2014-02, Vol.47 (2), p.473-474

2014

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Therapeutic Outcomes Between Surgical Resection Followed By R-CHOP and R-CHOP Alone for Localized Primary Intestinal Diffuse Large B-cell Lymphoma

American journal of clinical oncology, 2014-04, Vol.37 (2), p.182-187

2014

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer

World journal of gastroenterology : WJG, 2012-03, Vol.18 (10), p.1104-1109

2012

Link zum Volltext

Verfügbarkeit prüfen

The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center

Supportive care in cancer, 2015-08, Vol.23 (8), p.2427-2433

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma

Cancer, 2015-08, Vol.121 (15), p.2612-2617

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.937

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.749)
Mit Volltextzugriff
(1.852)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.209)
Life Sciences & Biomedicine
(949)
Humans
(575)
Male
(428)
Female
(409)
Middle Aged
(316)
Aged
(271)
Adult
(213)
Animals
(193)
Technology
(185)
Physical Sciences
(172)
Original
(159)
Oncology
(152)
Treatment Outcome
(119)
Biological And Medical Sciences
(118)
Republic Of Korea
(111)
Chemistry
(108)
Materials Science
(108)
Risk Factors
(107)
Science & Technology - Other Topics
(105)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(40)
... seit 30 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Long‐term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real‐world data (KCSG LU20‐11)

Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)

Quality of end‐of‐life care in patients with hematologic malignancies: A retrospective cohort study

Characteristics and Outcomes of Patients Admitted to the Acute Palliative Care Unit From the Emergency Center

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR - or ALK -Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

Evaluation of Outcomes of the Busan Community-based Palliative Care Project in Korea

Avoidable and Unavoidable Visits to the Emergency Department Among Patients With Advanced Cancer Receiving Outpatient Palliative Care

Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01)

Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study

Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas

Multi-center, randomized, double-blind, placebo-controlled, exploratory study to evaluate the efficacy and safety of HAD-B1 for dose-finding in EGFR positive and locally advanced or metastatic NSCLC subjects who need Afatinib therapy: Study protocol clinical trial (SPIRIT Compliant)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer

Comprehensive approaches to managing delirium in patients with advanced cancer

Totality outcome of afatinib sequential treatment in patients with EGFR mutation-positive non-small cell lung cancer in South Korea (TOAST): Korean Cancer Study Group (KCSG) LU-19-22

Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors

Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01)

Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01)

Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter Study

Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study

Opioid Withdrawal Syndrome After Treatment With Low-Dose Extended-Release Oxycodone and Naloxone in a Gastric Cancer Patient With Portal Vein Thrombosis

Avoidable and Unavoidable Visits to the Emergency Department Among Advanced Cancer Patients (AdCa) Followed by the Supportive Care (SCPC) Outpatient Clinic (S715)

Comparison of Therapeutic Outcomes Between Surgical Resection Followed By R-CHOP and R-CHOP Alone for Localized Primary Intestinal Diffuse Large B-cell Lymphoma

Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer

The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center

Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma

Suchergebnisse filtern